The evidence reference
Liraglutide
Saxenda
Approved productSources checked 2026-10-27
Reading this profile
Start with the path into the study, then consider the audience named in the claim. Read the entry criteria, recruitment description, and reasons people were excluded. If a headline addresses a broad group, ask whether the report explains how its selected participants represent that group. Keep selection at enrollment separate from participation through the end: a report may answer different questions depending on whose results it includes. This reading exercise is about locating the boundary of a conclusion. It does not require deciding that everyone inside or outside a study would have the same experience.
Formulation and route
Subcutaneous injection.
Mechanism
Activates the GLP-1 receptor.
Research evidence
Randomized trials.
Limits of the evidence
Check other products separately.
Safety context
The label warns about severe gastrointestinal reactions.
Questions to take further
- How were participants selected for the study described in the report?
- Does the headline address a broader population than the enrollment criteria?
- Whose results were included when the authors calculated the reported outcome?
Original sources
- SAXENDANLM · Checked 2026-10-27
Continue your research
An educational reference from the Comparison Desk. AI-assisted; not reviewed by a licensed clinician. This library does not provide prescriptions or instructions for self-treatment.